Home

Zablácený vázaný aktivita p53 tumor marker vstříknout fosilní nečestný

Cathepsin L activated by mutant p53 and Egr-1 promotes ionizing  radiation-induced EMT in human NSCLC | Journal of Experimental & Clinical  Cancer Research | Full Text
Cathepsin L activated by mutant p53 and Egr-1 promotes ionizing radiation-induced EMT in human NSCLC | Journal of Experimental & Clinical Cancer Research | Full Text

How does p53 induce apoptosis and how does this relate to p53-mediated  tumour suppression? | Cell Death & Differentiation
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? | Cell Death & Differentiation

Frontiers | Mutant p53 in Cancer Progression and Targeted Therapies
Frontiers | Mutant p53 in Cancer Progression and Targeted Therapies

Distribution of positive tumor marker stains, alone or in select... |  Download Table
Distribution of positive tumor marker stains, alone or in select... | Download Table

The p53 pathway in breast cancer | Breast Cancer Research | Full Text
The p53 pathway in breast cancer | Breast Cancer Research | Full Text

The p53 Protein: Mutations, Cancer & Cell Signalling - Assay Genie
The p53 Protein: Mutations, Cancer & Cell Signalling - Assay Genie

Exploring the p53 connection of cervical cancer pathogenesis involving  north-east Indian patients | PLOS ONE
Exploring the p53 connection of cervical cancer pathogenesis involving north-east Indian patients | PLOS ONE

p53 Antibody (D07) - Bio SB
p53 Antibody (D07) - Bio SB

p53 - Wikipedia
p53 - Wikipedia

An unexpected role for p53 in regulating cancer cell–intrinsic PD-1 by  acetylation | Science Advances
An unexpected role for p53 in regulating cancer cell–intrinsic PD-1 by acetylation | Science Advances

Biology | Free Full-Text | A Glance of p53 Functions in Brain Development,  Neural Stem Cells, and Brain Cancer
Biology | Free Full-Text | A Glance of p53 Functions in Brain Development, Neural Stem Cells, and Brain Cancer

Tumor suppressive role for kinases phosphorylating p53 in DNA  damage‐induced apoptosis - Yogosawa - 2018 - Cancer Science - Wiley Online  Library
Tumor suppressive role for kinases phosphorylating p53 in DNA damage‐induced apoptosis - Yogosawa - 2018 - Cancer Science - Wiley Online Library

Clinical Implications of the p53 Tumor-Suppressor Gene | NEJM
Clinical Implications of the p53 Tumor-Suppressor Gene | NEJM

p53 may play a more important role in kidney cancer than previously thought
p53 may play a more important role in kidney cancer than previously thought

Tumor suppressor protein p53 expressed in yeast can remain diffuse, form a  prion, or form unstable liquid-like droplets - ScienceDirect
Tumor suppressor protein p53 expressed in yeast can remain diffuse, form a prion, or form unstable liquid-like droplets - ScienceDirect

Circulating Tumor Markers: Basic Concepts and Clinical Applications |  Basicmedical Key
Circulating Tumor Markers: Basic Concepts and Clinical Applications | Basicmedical Key

p53 and metabolism: from mechanism to therapeutics | Oncotarget
p53 and metabolism: from mechanism to therapeutics | Oncotarget

The p53 transcriptional response across tumor types reveals core and  senescence-specific signatures modulated by long noncoding RNAs | PNAS
The p53 transcriptional response across tumor types reveals core and senescence-specific signatures modulated by long noncoding RNAs | PNAS

p53 and Tumor Suppression: It Takes a Network: Trends in Cell Biology
p53 and Tumor Suppression: It Takes a Network: Trends in Cell Biology

Gain-of-function p53 protein transferred via small extracellular vesicles  promotes conversion of fibroblasts to a cancer-associated phenotype -  ScienceDirect
Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype - ScienceDirect

Frontiers | Cancer Stemness: p53 at the Wheel
Frontiers | Cancer Stemness: p53 at the Wheel

Frontiers | Promising New Tools for Targeting p53 Mutant Cancers: Humoral  and Cell-Based Immunotherapies
Frontiers | Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies